Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.
Current role of cannabis in therapeutics: A critical perspective.
Farm Hosp · 2026 Sep 4 · PubMed
Svenska: This article offers a critical overview of the therapeutic role of cannabis and cannabinoids following their recent regulation in Spain through Royal Decree 903/2025 for the use of standardized compounded formulations.
Endocannabinoid system dysregulation in non-communicable diseases: Implications for skeletal muscle health.
Exp Gerontol · 2026 Sep 4 · PubMed
Svenska: Non-communicable diseases (NCDs) and their associated skeletal muscle (SkM) degeneration substantially contribute to morbidity and mortality. Interestingly, the endocannabinoid system (ECS) is increasingly recognized as an important regulator of both NCD pathophysiology and SkM plasticity.
Regulated Cannabis Access in Basel
ClinicalTrials.gov (ACTIVE_NOT_RECRUITING) · 2026-09-02 · ClinicalTrials.gov
Svenska: The randomised controlled study on regulated cannabis access in pharmacies in Basel aims to investigate the effects of regulated cannabis access on consumption behaviour and mental and physical health in comparison to the illegal market.
Correction: Mechanistic insights into cannabidiol-mediated TrkB activation via FRS2 interaction in attenuating Alzheimer's disease pathology and cognitive impairment.
Mol Psychiatry · 2026 Sep 2 · PubMed